Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
Ye T, Wei X, Yin T, Xia Y, Li D, Shao B, Song X, He S, Luo M, Gao X, He Z, Luo C, Xiong Y, Wang N, Zeng J, Zhao L, Shen G, Xie Y, Yu L, Wei Y.
Ye T, et al.
Breast Cancer Res Treat. 2014 Feb;143(3):435-46. doi: 10.1007/s10549-013-2829-y. Epub 2014 Jan 8.
Breast Cancer Res Treat. 2014.
PMID: 24398778